121 related articles for article (PubMed ID: 23826219)
21. An Image-Based Identification of Aggressive Breast Cancer Circulating Tumor Cell Subtypes.
Kamal M; Wang YJ; Plummer S; Dickerson A; Yu M
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345005
[TBL] [Abstract][Full Text] [Related]
22. CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity.
Ffrench B; Kashdan E; Huang Y; Spillane CD; Cocchiglia S; Charmsaz S; Varešlija D; O'Brien C; Scholz D; Martin C; Gallagher M; Brooks DA; Brooks RD; Selemidis S; Gleeson N; AbuSaadeh F; O'Riain C; Kamran W; Flavin R; Young L; O'Toole SA; O'Leary JJ
Heliyon; 2023 Jan; 9(1):e13044. PubMed ID: 36747925
[TBL] [Abstract][Full Text] [Related]
23. Detection and Characterization of Circulating Tumor Cells Using Imaging Flow Cytometry-A Perspective Study.
Muchlińska A; Smentoch J; Żaczek AJ; Bednarz-Knoll N
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077716
[TBL] [Abstract][Full Text] [Related]
24. Live imaging and quantification of circulating potentially metastatic tumor cells in early pupal stage of
Chernet DY; Klassen L; Goertzen S; Malagon JN
MicroPubl Biol; 2022; 2022():. PubMed ID: 35783574
[TBL] [Abstract][Full Text] [Related]
25. A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.
Pillai SG; Siddappa CM; Ma C; Snider J; Kaushal M; Watson MA; Aft R
PLoS One; 2021; 16(5):e0246139. PubMed ID: 33989287
[TBL] [Abstract][Full Text] [Related]
26. Nanotechnology-Assisted Isolation and Analysis of Circulating Tumor Cells on Microfluidic Devices.
Cheng J; Liu Y; Zhao Y; Zhang L; Zhang L; Mao H; Huang C
Micromachines (Basel); 2020 Aug; 11(8):. PubMed ID: 32823926
[TBL] [Abstract][Full Text] [Related]
27. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
28. An Immune-Magnetophoretic Device for the Selective and Precise Enrichment of Circulating Tumor Cells from Whole Blood.
Chelakkot C; Ryu J; Kim MY; Kim JS; Kim D; Hwang J; Park SH; Ko SB; Park JW; Jung MY; Kim RN; Song K; Kim YJ; Choi YL; Lee HS; Shin YK
Micromachines (Basel); 2020 May; 11(6):. PubMed ID: 32486306
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell Analysis of Circulating Tumor Cells: Why Heterogeneity Matters.
Lim SB; Lim CT; Lim WT
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635038
[TBL] [Abstract][Full Text] [Related]
30. Liquid biopsy: one cell at a time.
Lim SB; Di Lee W; Vasudevan J; Lim WT; Lim CT
NPJ Precis Oncol; 2019; 3():23. PubMed ID: 31602399
[TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor Cells in Early Breast Cancer.
Thery L; Meddis A; Cabel L; Proudhon C; Latouche A; Pierga JY; Bidard FC
JNCI Cancer Spectr; 2019 Jun; 3(2):pkz026. PubMed ID: 31360902
[TBL] [Abstract][Full Text] [Related]
32. Liquid Biopsy in Solid Malignancy.
Scarlotta M; Simsek C; Kim AK
Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
[TBL] [Abstract][Full Text] [Related]
33. Continuous Separation of Circulating Tumor Cells from Whole Blood Using a Slanted Weir Microfluidic Device.
Yoon Y; Lee J; Ra M; Gwon H; Lee S; Kim MY; Yoo KC; Sul O; Kim CG; Kim WY; Park JG; Lee SJ; Lee YY; Choi HS; Lee SB
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30744156
[TBL] [Abstract][Full Text] [Related]
34. Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles.
Nanou A; Crespo M; Flohr P; De Bono JS; Terstappen LWMM
Cancers (Basel); 2018 Oct; 10(11):. PubMed ID: 30384500
[TBL] [Abstract][Full Text] [Related]
35. Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes.
Soler A; Cayrefourcq L; Mazard T; Babayan A; Lamy PJ; Assou S; Assenat E; Pantel K; Alix-Panabières C
Sci Rep; 2018 Oct; 8(1):15931. PubMed ID: 30374140
[TBL] [Abstract][Full Text] [Related]
36. How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring.
Zeune LL; de Wit S; Berghuis AMS; IJzerman MJ; Terstappen LWMM; Brune C
Cytometry A; 2018 Dec; 93(12):1202-1206. PubMed ID: 30246927
[TBL] [Abstract][Full Text] [Related]
37. Quantifying HER-2 expression on circulating tumor cells by ACCEPT.
Zeune L; van Dalum G; Decraene C; Proudhon C; Fehm T; Neubauer H; Rack B; Alunni-Fabbroni M; Terstappen LWMM; van Gils SA; Brune C
PLoS One; 2017; 12(10):e0186562. PubMed ID: 29084234
[TBL] [Abstract][Full Text] [Related]
38. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
39. Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer.
Jia S; Zhang R; Li Z; Li J
Oncotarget; 2017 Aug; 8(33):55632-55645. PubMed ID: 28903450
[TBL] [Abstract][Full Text] [Related]
40. Statistical performance of image cytometry for DNA, lipids, cytokeratin, & CD45 in a model system for circulation tumor cell detection.
Futia GL; Schlaepfer IR; Qamar L; Behbakht K; Gibson EA
Cytometry A; 2017 Jul; 91(7):662-674. PubMed ID: 28608985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
